Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

dr amanda kerr

dr amanda kerr

Amanda Kerr


Postdoctoral Epidemiologist

Amanda Kerr works in the Late Effects team working on systematic reviews of long term outcomes of cancer treatments.

She joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) as a research assistant with the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) in 2008.

Amanda went on to complete a PhD with Sarah Darby, investigating the cardiotoxic effects of anthracycline chemotherapy, graduating in 2016.